Bezlotoxumab, Fecal Microbiota Transplantation Similarly Effective At Preventing Recurrent Clostridioides Difficile Infection, Study Suggests

Healio (2/13, Stulpin) reports “bezlotoxumab and fecal microbiota transplantation were similarly effective at preventing both early and late recurrent Clostridioides difficile infection, according to a study published in Open Forum Infectious Diseases.” T...